{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Molecular docking", "SARS-CoV-2", "allium sativum", "coronavirus", "withania somnifera"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34038246", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "06"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "07"}], "Language": ["eng"], "ELocationID": ["10.1080/03639045.2021.1934857"], "Journal": {"ISSN": "1520-5762", "JournalIssue": {"Volume": "47", "Issue": "5", "PubDate": {"Year": "2021", "Month": "May"}}, "Title": "Drug development and industrial pharmacy", "ISOAbbreviation": "Drug Dev Ind Pharm"}, "ArticleTitle": "Reckoning \u03b3-Glutamyl-S-allylcysteine as a potential main protease (m<sup>pro</sup>) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation.", "Pagination": {"StartPage": "699", "EndPage": "710", "MedlinePgn": "699-710"}, "Abstract": {"AbstractText": ["Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2 or COVID-19), outbreak was first reported in December 2019 in the Wuhan, China. COVID-19 managed to spread worldwide and so far more than 9.1 million cases and more than 4.7 lakh death has been reported globally. Children, pregnant women, elderly population, immunocompromised patients, and patients with conditions like asthma, diabetes, etc. are highly vulnerable to COVID infection. Currently, there is no treatment available for COVID-19 infection. Traditional medicinal plants have provided bioactive molecules in the past that are efficiently used during conditions like cancer, malaria, microbial infections, immune-compromised states, etc. AYUSH India has recommended the use of <i>Curcuma longa, Allium sativum, Ocimum tenuiflorum</i>, and <i>Withania somnifera</i> for immune-boosting during SARS-CoV-2 infection. In the present study, we investigated the potential of 63-major bioactive molecules of these plants against SARS-CoV-2 main protease (M<sup>pro</sup>) through docking studies and compared the results with known inhibitor 11a. Our results proposed cuscohygrine, \u03b3-Glutamyl-S-allylcysteine, anahygrine, and S-allylcystein as the potent inhibitors against M<sup>pro</sup> identified using molecular docking and molecular simulation dynamics. Interestingly, these molecules are from <i>A. sativum</i>, and <i>W. somnifera</i>, which are known for their antimicrobial and immunomodulatory potential. None of the proposed molecules have earlier been reported as antiviral molecules. Our results predict very strong potential of these four-molecules against SARS-CoV-2 M<sup>pro</sup>, especially \u03b3-glutamyl-S-allylcysteine, as all four form hydrogen bonding with Glu166 that is a crucial residue for the formation of the biologically active dimeric form of M<sup>pro</sup>. Therefore, we strongly recommend further research on these biomolecules against SARS-CoV-2."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India."}], "LastName": "Parashar", "ForeName": "Arun", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Institute of Advanced Research, Gandhinagar, India."}, {"Identifier": [], "Affiliation": "Department of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad, India."}], "LastName": "Shukla", "ForeName": "Arpit", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Yeshiva University, New York, NY, USA."}], "LastName": "Sharma", "ForeName": "Ankush", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Chitkara University, Punjab, India."}], "LastName": "Behl", "ForeName": "Tapan", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Govt. College of Pharmacy, Rohru, India."}], "LastName": "Goswami", "ForeName": "Dweipayan", "Initials": "D"}, {"Identifier": ["0000-0003-0485-5076"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Chitkara University, Punjab, India."}], "LastName": "Mehta", "ForeName": "Vineet", "Initials": "V"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Drug Dev Ind Pharm", "NlmUniqueID": "7802620", "ISSNLinking": "0363-9045"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Dipeptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "gamma-glutamyl-S-allylcysteine"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Child"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": [], "DescriptorName": "Dipeptides"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": [], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "Authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Richman D, Whitley R, Hayden F. Clinical virology. 2016. https://books.google.com/books?hl=en&lr=&id=G9zIDwAAQBAJ&oi=fnd&pg=PT8&dq=26.%09Richman,+D.+D.,+Whitley,+R.+J.,+%26+Hayden,+F.+G.+(2016).+Clinical+Virology.+John+Wiley+%26+Sons.&ots=FcgFv6n-FO&sig=EbNz-R7HQoV-m6GkdlQQxIQNpDQ."}, {"Citation": "Pyrc K, Dijkman R, Deng L, et al.  Mosaic structure of human coronavirus NL63, one thousand years of evolution. Elsevier. 2006. Retrieved July 9, 2020, from https://www.sciencedirect.com/science/article/pii/S0022283606012988.", "ArticleIdList": ["PMC7094706", "17054987"]}, {"Citation": "Schwartz DA, Graham AL.. Potential maternal and infant outcomes from coronavirus 2019-NCOV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12(2):194.", "ArticleIdList": ["PMC7077337", "32050635"]}, {"Citation": "Van Der Hoek L, Pyrc K, Jebbink MF, et al. . Identification of a new human coronavirus. Nat Med. 2004;10(4):368\u2013373.", "ArticleIdList": ["PMC7095789", "15034574"]}, {"Citation": "Woo PCY, Lau SKP, Chu C-M, et al. . Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from Patients with Pneumonia. JVI. 2005;79(2):884\u2013895.", "ArticleIdList": ["PMC538593", "15613317"]}, {"Citation": "Lau SKP, Patrick CYW, Yip CCY, et al. . Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol. 2006;44(6):2063\u20132071.", "ArticleIdList": ["PMC1489438", "16757599"]}, {"Citation": "Reina J, L\u00f3pez-Causap\u00e9 C, Rojo-Molinero E, et al. . Clinico-epidemiological characteristics of acute respiratory infections by coronavirus OC43, NL63 and 229E. Revista Cl\u00ednica Espa\u00f1ola (English Edition). 2014;214(9):499\u2013504.", "ArticleIdList": ["PMC7103947", "24958321"]}, {"Citation": "Drosten C, G\u00fcnther S, Preiser W, et al. . Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967\u20131976.", "ArticleIdList": ["12690091"]}, {"Citation": "Hui DS. Epidemic and emerging coronaviruses (severe acute respiratory syndrome and middle east respiratory syndrome). Clin Chest Med. 2017;38(1):71\u201386.", "ArticleIdList": ["PMC7131795", "28159163"]}, {"Citation": "Perlman S. Another decade, another coronavirus. N Engl J Med. 2020;382(8):760\u2013762. Issue Massachussetts Medical Society.", "ArticleIdList": ["PMC7121143", "31978944"]}, {"Citation": "Song Z, Xu Y, Bao L, et al. . From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11(1):59.", "ArticleIdList": ["PMC6357155", "30646565"]}, {"Citation": "Wu F, Zhao S, Yu B, et al. . A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265\u2013269.", "ArticleIdList": ["PMC7094943", "32015508"]}, {"Citation": "Zhou P, Yang XL, Wang XG, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u2013273.", "ArticleIdList": ["PMC7095418", "32015507"]}, {"Citation": "Zhu N, Zhang D, Wang W, et al. ; China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u2013733.", "ArticleIdList": ["PMC7092803", "31978945"]}, {"Citation": "Munster VJ, Koopmans M, van Doremalen N, et al. . A novel coronavirus emerging in China \u2013 Key questions for impact assessment. N Engl J Med. 2020;382(8):692\u2013694.", "ArticleIdList": ["31978293"]}, {"Citation": "Jin Z, Du X, Xu Y, et al. . Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289\u2013293.", "ArticleIdList": ["32272481"]}, {"Citation": "Kong R, Yang G, Xue R, et al. . \nCOVID-19 Docking Server: An interactive server for docking small molecules, peptides and antibodies against potential targets of COVID-19. J ArXiv Preprint. 2020. https://arxiv.org/abs/2003.00163", "ArticleIdList": ["PMC7558834", "32692801"]}, {"Citation": "Chen Z, Nakamura T.. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother Res. 2004;18(7):592\u2013594.", "ArticleIdList": ["15305324"]}, {"Citation": "Rao P, Shukla A, Parmar P, et al. . Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (Mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation. Biophys Chem. 2020;264:106425.", "ArticleIdList": ["PMC7836334", "32663708"]}, {"Citation": "Ali I, Alharbi OM.. COVID-19: disease, management, treatment, and social impact. Sci Total Environ. 2020;728:138861\u2013138866.", "ArticleIdList": ["PMC7175909", "32344226"]}, {"Citation": "AYUSH . Ayurveda\u2019s immunity boosting measures for self care during COVID 19 crisis. The Ministry of Ayurvedic, Yoga and Naturopathy, Unani, Siddha and Homeopathy 2020. http://ayush.gov.in/event/ayurveda-immunity-boosting-measures-self-care-during-covid-19-crisis."}, {"Citation": "Kumar V, Dhanjal JK, Kaul SC, et al. . Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn. 2020:1\u201313.", "ArticleIdList": ["PMC7284143", "32431217"]}, {"Citation": "Xu Y, Su D, Zhu L, et al. . S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1. J Ovarian Res. 2018;11(1):39.", "ArticleIdList": ["PMC5952516", "29759079"]}, {"Citation": "Kumar D, Arya V, Kaur R, et al. . A review of immunomodulators in the Indian traditional health care system. J Microbiol Immunol Infect. 2012;45(3):165\u2013184.", "ArticleIdList": ["22154993"]}, {"Citation": "Gautam S, Gautam A, Chhetri S, et al. . Immunity against covid-19: potential role of Ayush Kwath. J Ayur Integr Med. 2020. DOI:10.1016/j.jaim.2020.08.003", "ArticleIdList": ["10.1016/j.jaim.2020.08.003", "PMC7430223", "32837101"]}, {"Citation": "Dai W, Zhang B, Jiang XM, et al. . Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020;368(6497):1331\u20131335.", "ArticleIdList": ["PMC7179937", "32321856"]}, {"Citation": "Jin Z, Du X, Xu Y, et al. . Structure of M pro from COVID-19 virus and discovery of its inhibitors. Nature. 2020;582(7811):289\u2013293.", "ArticleIdList": ["32272481"]}, {"Citation": "Joshi RS, Jagdale SS, Bansode SB, et al. . Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. J Biomol Struc Dyn. 2020;39(9):3099\u20133114.", "ArticleIdList": ["PMC7212545", "32329408"]}, {"Citation": "Kumar Y, Singh H, Patel CN.. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J Infect Public Health. 2020;13(9):1210\u20131223.", "ArticleIdList": ["PMC7297718", "32561274"]}, {"Citation": "Parmar P, Shukla A, Rao P, et al. . The rise of gingerol as anti-QS molecule: darkest episode in the LuxR-mediated bioluminescence saga. Bioorg Chem. 2020;99:103823.", "ArticleIdList": ["32283347"]}, {"Citation": "Zheng J, Frisch MJ.. Efficient geometry minimization and transition structure optimization using interpolated potential energy surfaces and iteratively updated hessians. J Chem Theory Comput. 2017;13(12):6424\u20136432.", "ArticleIdList": ["29045137"]}, {"Citation": "Reulecke I, Lange G, Albrecht J, et al. . Towards an integrated description of hydrogen bonding and dehydration: Decreasing false positives in virtual screening with the HYDE scoring function. ChemMedChem. 2008;3(6):885\u2013897.", "ArticleIdList": ["18384086"]}, {"Citation": "Schneider N, Lange G, Hindle S, et al. . A consistent description of HYdrogen bond and DEhydration energies in protein-ligand complexes: Methods behind the HYDE scoring function. J Comput Aided Mol Des. 2013;27(1):15\u201329.", "ArticleIdList": ["23269578"]}, {"Citation": "Wang W, Donini O, Reyes CM, et al. . Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. Annu Rev Biophys Biomol Struct. 2001;30(1):211\u2013243.", "ArticleIdList": ["11340059"]}, {"Citation": "Abad-Zapatero C. Ligand efficiency indices as guideposts for drug discovery. 2005. Retrieved July 9, 2020, from www.drugdiscoverytoday.com.", "ArticleIdList": ["15809192"]}, {"Citation": "Hopkins AL, Groom CR, Alex A.. Ligand efficiency: a useful metric for lead selection. Drug Discov Today. 2004;9(10):430\u2013431.", "ArticleIdList": ["15109945"]}, {"Citation": "Bekker H, Berendsen HJC, Dijkstra EW, et al. . Gromacs: a parallel computer for molecular dynamics simulations. Singapore: World Scientific Publishing; 1993."}, {"Citation": "Pronk S, P\u00e1ll S, Schulz R, et al. . GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29(7):845\u2013854.", "ArticleIdList": ["PMC3605599", "23407358"]}, {"Citation": "Van Der Spoel D, Lindahl E, Hess B, et al. . %J J. of computational chemistry. GROMACS. 2005;26(16):1701\u20131718.", "ArticleIdList": ["16211538"]}, {"Citation": "Zoete V, Cuendet MA, Grosdidier A, et al. . SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem. 2011;32(11):2359\u20132368.", "ArticleIdList": ["21541964"]}, {"Citation": "Berendsen HJC, Postma JPM, van Gunsteren WF, et al. . Interaction models for water in relation to protein hydration. In: Intermolecular forces. Dordrecht, Netherlands: Springer; 1981. p. 331\u2013342"}, {"Citation": "Hess B, Bekker H, Berendsen HJC, et al. . LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18(12):1463\u20131472."}, {"Citation": "Kollman PA, Massova I, Reyes C, et al. . Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000;33(12):889\u2013897.", "ArticleIdList": ["11123888"]}, {"Citation": "Massova I, Kollman PA.. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect Drug Disc Design. 2000;18(1):113\u2013135."}, {"Citation": "Wang J, Hou T, Xu X.. Recent advances in free energy calculations with a combination of molecular mechanics and continuum models. CAD. 2006;2(3):287\u2013306."}, {"Citation": "Wang J, Wang W, Kollman PA, et al. . Antechamber: an accessory software package for molecular mechanical calculations. J J. Am. Chem. Soc. 2001;222:U403."}, {"Citation": "Pires DEV, Blundell TL, Ascher DB.. PkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066\u20134072.", "ArticleIdList": ["PMC4434528", "25860834"]}, {"Citation": "Bhardwaj VK, Purohit R.. Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation. J Biomol Struct Dyn. 2020:1\u201310.", "ArticleIdList": ["32448055"]}, {"Citation": "Lionta E, Spyrou G, Vassilatis DK, et al. . \nStructure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Topics Med Chem\n2014;14. https://www.ingentaconnect.com/content/ben/ctmc/2014/00000014/00000016/art00008.", "ArticleIdList": ["PMC4443793", "25262799"]}, {"Citation": "Shukla A, Parmar P, Rao P, et al. . Twin peaks: presenting the antagonistic molecular interplay of curcumin with LasR and LuxR quorum sensing pathways. Curr Microbiol. 2020;77(8):1800\u20131810.", "ArticleIdList": ["32333184"]}, {"Citation": "Kumar V, Dhanjal J, Kaul S. Withanone and Caffeic Acid Phenethyl Ester are Predicted to Interact with Main Protease (Mpro) of SARS-CoV-2 and Inhibit its Activity. Taylor & Francis. 2020. Retrieved July 9, 2020, from https://www.tandfonline.com/doi/abs/10.1080/07391102.2020.1772108.", "ArticleIdList": ["10.1080/07391102.2020.1772108", "PMC7284143", "32431217"]}, {"Citation": "Yang H, Bartlam M, Rao Z.. Drug design targeting the main protease, the achilles' heel of coronaviruses. Curr Pharm Des. 2006;12(35):4573\u20134590.", "ArticleIdList": ["17168763"]}, {"Citation": "Braz HLB, de Moraes Silveira JA, Marinho AD, et al. . In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Int J Antimicrob Agents. 2020;56(3):106119.", "ArticleIdList": ["PMC7390782", "32738306"]}, {"Citation": "Li Z, Li X, Huang YY, et al. . Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Proc Natl Acad Sci USA. 2020;117(44):27381\u201327387.", "ArticleIdList": ["PMC7959488", "33051297"]}, {"Citation": "Rebeaud ME, Zores F.. SARS-CoV-2 and the use of chloroquine as an antiviral treatment. Front Med. 2020;7:184.", "ArticleIdList": ["PMC7193267", "32391371"]}, {"Citation": "Singh AK, Singh A, Shaikh A, et al. . Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diab Metab Syndr. 2020;14(3):241\u2013246.", "ArticleIdList": ["PMC7102587", "32247211"]}, {"Citation": "Rubio NC, Thurmann D, Krumbiegel F, et al. . Behaviour of hygrine and cuscohygrine in illicit cocaine production establishes their use as markers for chewing coca leaves in contrast with cocaine abuse. Drug Test Anal. 2017;9(2):323\u2013326.", "ArticleIdList": ["27004438"]}, {"Citation": "Vetvicka V, Vetvickova J.. Immune enhancing effects of WB365, a novel combination of Ashwagandha (Withania somnifera) and Maitake (Grifola frondosa) extracts. N Am J Med Sci. 2011;3(7):320\u2013324.", "ArticleIdList": ["PMC3336880", "22540105"]}, {"Citation": "Yamada K, Hung P, Park TK, et al. . A comparison of the immunostimulatory effects of the medicinal herbs Echinacea, Ashwagandha and Brahmi. J Ethnopharmacol. 2011;137(1):231\u2013235.", "ArticleIdList": ["21619924"]}, {"Citation": "Ziauddin M, Phansalkar N, Patki P, et al. . Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol. 1996;50(2):69\u201376.", "ArticleIdList": ["8866726"]}, {"Citation": "Jain J, Narayanan V, Chaturvedi S, et al. . In vivo evaluation of Withania somnifera-based indian traditional formulation (Amukkara Choornam), against chikungunya virus-induced morbidity and arthralgia. J Evid Based Integr Med. 2018;23:2156587218757661.", "ArticleIdList": ["PMC5871050", "29484895"]}, {"Citation": "Agbana YL, Ni Y, Zhou M, et al. . Garlic-derived bioactive compound S-allylcysteine inhibits cancer progression through diverse molecular mechanisms. Nutr Res. 2020;73:1\u201314.", "ArticleIdList": ["31835095"]}, {"Citation": "Goncagul G, Ayaz E.. Antimicrobial effect of garlic (Allium sativum) and traditional medicine. J Anim Vet Adv. 2010;9(1):1\u20134.", "ArticleIdList": ["19929845"]}, {"Citation": "Syu J-N, Yang M-D, Tsai S-Y, et al. . S-allylcysteine improves blood flow recovery and prevents ischemic injury by augmenting neovasculogenesis. Cell Transplant. 2017;26(10):1636\u20131647.", "ArticleIdList": ["PMC5753981", "29251114"]}, {"Citation": "Tauseef Sultan M, Sadiq Buttxs M, Nasir Qayyum MM, et al. . Immunity: plants as effective mediators. Crit Rev Food Sci Nutr. 2014;54(10):1298\u20131308.", "ArticleIdList": ["24564587"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "5", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "26", "Hour": "17", "Minute": "19"}, {"Year": "2021", "Month": "6", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34038246", "PMC8204316", "10.1080/03639045.2021.1934857"]}}], "PubmedBookArticle": []}